Frontlight ResearchEarly access
Trial site
Centro de Estudios Clínicos de Querétaro (CECLIQ)
- 4running trials
- 3closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes4 trials
- Chronic kidney disease2 trials
- Heart failure2 trials
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Completed3 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1 trial
Running trials
Not yet recruiting
Recruiting
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Crohn's disease1 recruiting
- Obesity1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 14 Nov 2026